Holen Sie sich die Stockscreener-App
287.46
2.06%
5.80
Handel nachbörslich:
287.46
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$281.66
Offen:
$285.12
24-Stunden-Volumen:
1.94M
Relative Volume:
3.07
Marktkapitalisierung:
$17.11B
Einnahmen:
$2.91B
Nettoeinkommen (Verlust:
$622.64M
KGV:
27.43
EPS:
10.48
Netto-Cashflow:
$620.14M
1W Leistung:
-0.73%
1M Leistung:
-16.10%
6M Leistung:
-29.60%
1J Leistung:
-6.43%
1-Tages-Spanne:
$284.76
$291.62
1-Wochen-Bereich:
$279.62
$299.60
52-Wochen-Spanne:
$279.62
$423.56
Waters Corp Stock (WAT) Company Profile
Firmenname
Waters Corp
Sektor
Branche
Telefon
(508) 478-2000
Adresse
34 MAPLE ST, MILFORD, MA
Vergleichen Sie WAT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WAT
Waters Corp
|
287.46 | 17.23B | 2.91B | 622.64M | 620.14M | 10.48 |
|
TMO
Thermo Fisher Scientific Inc
|
427.62 | 157.79B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
189.91 | 138.02B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
532.00 | 42.36B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.19 | 32.08B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
187.38 | 27.28B | 15.50B | 1.33B | 2.16B | 7.34 |
Waters Corp Stock (WAT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-31 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-03-26 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-02-13 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-08-01 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2023-11-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Neutral |
| 2022-05-18 | Eingeleitet | Barclays | Overweight |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-04-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-07-06 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2021-01-07 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2020-12-17 | Hochstufung | Cleveland Research | Underperform → Buy |
| 2020-12-16 | Hochstufung | Citigroup | Sell → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-07-28 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2020-07-16 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2020-01-08 | Herabstufung | Needham | Hold → Underperform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Sell |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2019-07-16 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2019-06-12 | Herabstufung | Cleveland Research | Neutral → Underperform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-01-24 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2019-01-03 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-01-03 | Eingeleitet | Needham | Hold |
| 2018-12-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2018-11-30 | Herabstufung | Goldman | Neutral → Sell |
| 2018-10-11 | Hochstufung | Cleveland Research | Sell → Neutral |
Alle ansehen
Waters Corp Aktie (WAT) Neueste Nachrichten
What drives Waters Corporation stock pricePowerful market insights - jammulinksnews.com
Inside the deal: Waters CEO Udit Batra defends $17.5B merger with BD unit - The Business Journals
Mass Spectrometry Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Waters Lead with Robust Portfolios, Strategic Expansions, and Innovation-Driven Growth - Yahoo Finance
Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal - MSN
Waters Corp (WAT) Shares Decline 3.39% Amid Analyst Forecast - AInvest
Waters downgraded at Wells Fargo after Becton, Dickinson deal - MSN
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures - MSN
Under CEO Udit Batra's Leadership, Waters to Merge with BD Unit in $17.5 Billion Deal to Create Life Sciences Powerhouse - INDIA New England News
What analysts say about Waters Corporation stockMarket-beating performance - jammulinksnews.com
Waters Corp. stock underperforms Friday when compared to competitors - MarketWatch
Enovis, CONMED, Astrana Health, Privia Health, and Waters Corporation Stocks Trade Down, What You Need To Know - Yahoo Finance
Taxation With Representation: Wachtell, Slaughter And May - Law360
Is Waters Corporation a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com
Waters Corporation’s SWOT analysis: stock poised for growth amid biotech boom - Investing.com
Becton to merge unit with Waters in $17.5 billion deal - MSN
What to Expect From Waters Corporation's Next Quarterly Earnings Report - MSN
Waters Corp Is Taking On Thermo Fisher & Danaher With This $17.5 Billion Becton Dickinson Acquisition! - Smartkarma
Waters Corp. stock underperforms Tuesday when compared to competitors - MSN
symbol__ Stock Quote Price and Forecast - CNN
Becton to merge biosciences and diagnostics arm with Waters in $17.5 billion deal - MSN
Waters to merge with Becton's biosciences and diagnostics arm in $17.5 billion deal - MSN
WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters CorporationWAT - Business Wire
Waters (WAT) Stock Target Price Lowered by Baird Analyst | WAT S - GuruFocus
Waters (WAT) Price Target Reduced by Baird Analyst | WAT Stock N - GuruFocus
Waters Shares Dip After $17.5 Billion Merger Announcement with BD Biosciences Unit - MSN
Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks - MSN
Waters stock downgraded at Wells Fargo on BD deal (WAT:NYSE) - Seeking Alpha
Waters Corporation stock hits 52-week low at 297.03 USD By Investing.com - Investing.com Canada
UBS reiterates Neutral rating on Waters stock, maintains $360 price target - Investing.com Nigeria
Waters Corporation stock hits 52-week low at 297.03 USD - Investing.com
UBS reiterates Neutral rating on Waters stock, maintains $360 price target By Investing.com - Investing.com South Africa
Waters deal adds variables to ‘clean’ story, says Jefferies - Yahoo Finance
Waters stock rating reiterated at Hold by Stifel after BDX asset acquisition - Investing.com Nigeria
BD Partners With Waters to Build High-Volume Diagnostics Leader - Yahoo Finance
Street View: Waters’ $17.5 billion merger draws both optimism and caution - TradingView
Waters stock price target lowered to $330 from $375 at BofA Securities - Investing.com Nigeria
An $18 bln health deal faces risks outside the lab - Reuters
Waters stock price target lowered to $330 from $375 at BofA Securities By Investing.com - Investing.com South Africa
Waters Corp. & BD to become life science and diagnostics leader - ROI-NJ
Five things: Waters, lab leases, Legacy FC, classic cars and an ocean view - The Business Journals
Waters Corporation: A Path to Diversification via the Becton Diagnostics Merger - AInvest
Waters: Becoming A Diversified Giant Following The Becton Diagnostics Merger - Seeking Alpha
Waters' $17.5B BD Deal: A Bold Bet on Life Sciences Resilience Amid Tariff Storms - AInvest
Stock Movers: Waters, Autodesk, Palantir - Bloomberg
BD’s biosciences & diagnostics unit in $17.5B merger with Waters - BioWorld MedTech
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures By Reuters - Investing.com
Waters’ Purchase Of BD Biosciences & Dx Brings Growth Potential Alongside Trade-Offs - insights.citeline.com
Waters to combine with BD's biosciences unit, creating a $40B life science and diagnostics heavyweight - R&D World
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MGRM, WAT, VBTX on Behalf of Shareholders - GlobeNewswire Inc.
Becton Dickinson Finds a Partner for Its Biosciences and Diagnostics Business in Waters - Morningstar
Waters to Merge with BD's Life Science and Diagnostics Business - Morningstar
Finanzdaten der Waters Corp-Aktie (WAT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
7.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):